Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)
Condition(s):Hyperlipoproteinemia Type II; Homozygous Familial HypercholesterolemiaLast Updated:June 1, 2015Terminated